7 February 2019. Chairman with effect from 24 April 2019
Mr Brinsmead is currently a non-executive director of UDG Healthcare plc and Collagen Solutions plc. In addition, Chris is a member of council at Imperial College London.
Chris is Chairman of the Nomination Committee.
Key Strengths & Experience
Chris has worked in the global pharmaceutical sector for nearly forty years and brings significant international, operational and strategic expertise to the Board.
He was formerly the Chair of AstraZeneca Pharmaceuticals UK, President of AstraZeneca UK and Ireland and President of the Association of the British Pharmaceutical Industry (ABPI). He has previously held board positions at Domino Printing Sciences plc (2008-2016), Cambian Group plc (2014-2017), Proteus Digital Health Inc (2010-2015) and The Wesleyan Assurance Society (2010-2019). In addition, Chris was Independent Advisor to the Prime Minister and other senior government ministers Life Sciences from 2010 to 2017.
Chris was appointed a CBE in January 2015. He holds a BSc in Civil Engineering from Nottingham University and an MSc in Business Science from Manchester Business School.